Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.46 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.43 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22633971 | 0.82 | KIF11 (0.47) | FFAR4NCOA1NCOA3FFAR1AR | |
| SCHEMBL22634024 | 0.81 | NCOA1 (0.42) | FFAR4NCOA1NCOA3FFAR1SLC6A4 | |
| SCHEMBL17840231 | 0.77 | GPR3 (0.50) | FFAR4FFAR1OPRM1OPRK1HCRTR1 | |
| SCHEMBL6098538 | 0.75 | NCOA1 (0.47) | FFAR4NCOA1NCOA3FFAR1AR | |
| SCHEMBL2090173 | 0.74 | FFAR4 (0.46) | FFAR4SCN9ATRPA1 | |
| SCHEMBL2090267 | 0.73 | ABL1 (0.45) | FFAR4NCOA1NCOA3FFAR1AR | |
| SCHEMBL16915411 | 0.72 | FFAR4 (0.43) | FFAR4FFAR1CHRM5SCN9AGRIN2B | |
| SCHEMBL31532198 | 0.72 | FFAR4 (0.43) | FFAR4FFAR1CHRM5SCN9AGRIN2B | |
| SCHEMBL306822 | 0.71 | FFAR4 (0.55) | FFAR4SCN9ATRPA1 | |
| SCHEMBL29788132 | 0.71 | FFAR4 (0.55) | FFAR4SCN9ATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10988494-B2 | Europium complex | TOSOH CORPORATION (JP) | 2021-04-27 | — | — | US | disclosed |
| US-20200354389-A1 | EUROPIUM COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10988494-B2 | Europium complex | SSB, XPA, UACA | FFAR4 2665/4885NCOA1 113/4885NCOA3 98/4885 |
| US-20200354389-A1 | EUROPIUM COMPLEX | SSB, XPA, UACA | FFAR4 2665/4885NCOA1 113/4885NCOA3 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.